DK0984982T3 - LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem - Google Patents

LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem

Info

Publication number: DK0984982T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical compositions; compositions containing; peptide analogues; analogues; peptide
Prior art date: 1997-06-02

Application number

DK98924306T

Other languages

Danish (da)

English (en)

Inventor

Remi Delansorne

Jacques Paris

Original Assignee

Theramex

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-02

Filing date

1998-05-06

Publication date

2001-11-12

1998-05-06 Application filed by Theramex filed Critical Theramex

2001-11-12 Application granted granted Critical

2001-11-12 Publication of DK0984982T3 publication Critical patent/DK0984982T3/da

Links

101000904177 Clupea pallasii Gonadoliberin-1 Proteins 0.000 title 1
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 title 1
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 title 1
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Pregnancy & Childbirth (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK98924306T 1997-06-02 1998-05-06 LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem DK0984982T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP97401212A EP0882736A1 (fr)	1997-06-02	1997-06-02	Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant
PCT/EP1998/002802 WO1998055505A1 (fr)	1997-06-02	1998-05-06	Analogues de peptides de lh-rh, utilisation de ces derniers et compositions pharmaceutiques les contenant

Publications (1)

Publication Number	Publication Date
DK0984982T3 true DK0984982T3 (da)	2001-11-12

Family

ID=8229769

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98924306T DK0984982T3 (da)	1997-06-02	1998-05-06	LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem

Country Status (37)

Country	Link
US (1)	US6586402B1 (fr)
EP (2)	EP0882736A1 (fr)
JP (1)	JP4346115B2 (fr)
KR (1)	KR100582510B1 (fr)
CN (1)	CN1134450C (fr)
AP (1)	AP1195A (fr)
AR (1)	AR011734A1 (fr)
AT (1)	ATE204297T1 (fr)
AU (1)	AU746132B2 (fr)
BR (1)	BR9809910A (fr)
CA (1)	CA2292846C (fr)
CO (1)	CO4790174A1 (fr)
CZ (1)	CZ299308B6 (fr)
DE (1)	DE69801369T2 (fr)
DK (1)	DK0984982T3 (fr)
DZ (1)	DZ2509A1 (fr)
EE (1)	EE03879B1 (fr)
ES (1)	ES2166166T3 (fr)
HU (1)	HUP0003592A3 (fr)
ID (1)	ID24520A (fr)
IL (1)	IL133210A0 (fr)
JO (1)	JO2034B1 (fr)
MA (1)	MA26502A1 (fr)
MY (1)	MY122262A (fr)
NO (1)	NO321786B1 (fr)
NZ (1)	NZ501463A (fr)
OA (1)	OA11305A (fr)
PE (1)	PE84999A1 (fr)
PL (1)	PL195474B1 (fr)
PT (1)	PT984982E (fr)
RU (1)	RU2212247C2 (fr)
SI (1)	SI0984982T1 (fr)
TN (1)	TNSN98075A1 (fr)
TR (1)	TR199902997T2 (fr)
TW (1)	TW479062B (fr)
WO (1)	WO1998055505A1 (fr)
ZA (1)	ZA983992B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0882736A1 (fr) *	1997-06-02	1998-12-09	Laboratoire Theramex S.A.	Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant
US20020071829A1 (en) *	1999-04-15	2002-06-13	Richard Boyd	Normalization of defective T cell responsiveness through manipulation of thymic regeneration
KR20040018302A (ko) *	2000-10-13	2004-03-03	모나쉬 유니버시티	흉선 재생의 조작을 통한 이식체 수용능의 개선
GB0307777D0 (en)	2003-04-04	2003-05-07	Medical Res Council	Conjugate compounds
DE102004033902A1 (de) *	2004-07-14	2006-02-16	Zentaris Gmbh	Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's)
WO2007070659A2 (fr) *	2005-12-14	2007-06-21	Ambrx, Inc.	Compositions contenant des acides aminés et polypeptides non naturels, procédés mettant en jeu ceux-ci et utilisations de ceux-ci
CN102675418B (zh) *	2011-03-15	2016-04-20	中国人民解放军军事医学科学院毒物药物研究所	Lhrh拮抗剂衍生物、其制备方法及用途
WO2013140785A1 (fr) *	2012-03-18	2013-09-26	国立大学法人九州大学	Appareil, système et procédé pour l'analyse d'un échantillon d'une maladie
US9339457B2 (en)	2013-03-13	2016-05-17	Transdermal Biotechnology, Inc.	Cardiovascular disease treatment and prevention
US9393264B2 (en)	2013-03-13	2016-07-19	Transdermal Biotechnology, Inc.	Immune modulation using peptides and other compositions
US9314417B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Treatment of skin, including aging skin, to improve appearance
US9750787B2 (en)	2013-03-13	2017-09-05	Transdermal Biotechnology, Inc.	Memory or learning improvement using peptide and other compositions
US9241899B2 (en)	2013-03-13	2016-01-26	Transdermal Biotechnology, Inc.	Topical systems and methods for treating sexual dysfunction
US9295636B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Wound healing using topical systems and methods
US9724419B2 (en)	2013-03-13	2017-08-08	Transdermal Biotechnology, Inc.	Peptide systems and methods for metabolic conditions
US9387159B2 (en)	2013-03-13	2016-07-12	Transdermal Biotechnology, Inc.	Treatment of skin, including aging skin, to improve appearance
US9687520B2 (en)	2013-03-13	2017-06-27	Transdermal Biotechnology, Inc.	Memory or learning improvement using peptide and other compositions
US20140271731A1 (en)	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Cardiovascular disease treatment and prevention
US9849160B2 (en) *	2013-03-13	2017-12-26	Transdermal Biotechnology, Inc.	Methods and systems for treating or preventing cancer
US20140271938A1 (en)	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Systems and methods for delivery of peptides
US9295647B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Systems and methods for delivery of peptides
US9314422B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Peptide systems and methods for metabolic conditions
US9320706B2 (en)	2013-03-13	2016-04-26	Transdermal Biotechnology, Inc.	Immune modulation using peptides and other compositions
US9295637B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Compositions and methods for affecting mood states
US9314433B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Methods and systems for treating or preventing cancer
US9314423B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Hair treatment systems and methods using peptides and other compositions
US9320758B2 (en)	2013-03-13	2016-04-26	Transdermal Biotechnology, Inc.	Brain and neural treatments comprising peptides and other compositions
US20140271937A1 (en)	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Brain and neural treatments comprising peptides and other compositions
US9393265B2 (en)	2013-03-13	2016-07-19	Transdermal Biotechnology, Inc.	Wound healing using topical systems and methods
CN104418936B (zh) *	2013-08-20	2018-06-05	中国人民解放军军事医学科学院毒物药物研究所	Lhrh拮抗剂衍生物及其药物用途
CN114014913B (zh) *	2022-01-10	2022-03-29	浙江湃肽生物有限公司南京分公司	醋酸曲普瑞林的纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO139560C (no) *	1972-04-29	1979-04-04	Takeda Chemical Industries Ltd	Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
DE2424287A1 (de) *	1974-05-18	1975-12-04	Hoechst Ag	Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
NL7505590A (nl) *	1974-05-18	1975-11-20	Hoechst Ag	Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
US4565804A (en) *	1984-09-07	1986-01-21	The Salk Institute For Biological Studies	GnRH Antagonists VI
US5003011A (en) *	1985-04-09	1991-03-26	The Administrators Of The Tulane Educational Fund	Therapeutic decapeptides
US4935491A (en) *	1987-08-24	1990-06-19	Board Of Regents, The University Of Texas System	Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5140009A (en) *	1988-02-10	1992-08-18	Tap Pharmaceuticals, Inc.	Octapeptide LHRH antagonists
DE68928278T2 (de) *	1988-02-10	1998-03-12	Tap Pharmaceuticals Inc	Lhrh-analog
US5110904A (en) *	1989-08-07	1992-05-05	Abbott Laboratories	Lhrh analogs
EP0842946A1 (fr) *	1996-11-14	1998-05-20	Laboratoire Theramex S.A.	Analogues de LHRH à conformation forcée, leur utilisation et composés pharmaceutiques
EP0882736A1 (fr) *	1997-06-02	1998-12-09	Laboratoire Theramex S.A.	Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant

1997
- 1997-06-02 EP EP97401212A patent/EP0882736A1/fr not_active Withdrawn
1998
- 1998-05-06 AU AU76541/98A patent/AU746132B2/en not_active Ceased
- 1998-05-06 BR BR9809910-8A patent/BR9809910A/pt active Search and Examination
- 1998-05-06 RU RU2000100369/14A patent/RU2212247C2/ru not_active IP Right Cessation
- 1998-05-06 HU HU0003592A patent/HUP0003592A3/hu unknown
- 1998-05-06 DE DE69801369T patent/DE69801369T2/de not_active Expired - Lifetime
- 1998-05-06 JP JP50137899A patent/JP4346115B2/ja not_active Expired - Fee Related
- 1998-05-06 PL PL98337235A patent/PL195474B1/pl not_active IP Right Cessation
- 1998-05-06 ID IDW991505A patent/ID24520A/id unknown
- 1998-05-06 SI SI9830075T patent/SI0984982T1/xx unknown
- 1998-05-06 EE EEP199900546A patent/EE03879B1/xx not_active IP Right Cessation
- 1998-05-06 WO PCT/EP1998/002802 patent/WO1998055505A1/fr not_active Ceased
- 1998-05-06 ES ES98924306T patent/ES2166166T3/es not_active Expired - Lifetime
- 1998-05-06 NZ NZ501463A patent/NZ501463A/en not_active IP Right Cessation
- 1998-05-06 PT PT98924306T patent/PT984982E/pt unknown
- 1998-05-06 EP EP98924306A patent/EP0984982B1/fr not_active Expired - Lifetime
- 1998-05-06 CN CNB988071606A patent/CN1134450C/zh not_active Expired - Fee Related
- 1998-05-06 DK DK98924306T patent/DK0984982T3/da active
- 1998-05-06 AT AT98924306T patent/ATE204297T1/de active
- 1998-05-06 CZ CZ0432999A patent/CZ299308B6/cs not_active IP Right Cessation
- 1998-05-06 CA CA002292846A patent/CA2292846C/fr not_active Expired - Fee Related
- 1998-05-06 IL IL13321098A patent/IL133210A0/xx not_active IP Right Cessation
- 1998-05-06 KR KR1019997011279A patent/KR100582510B1/ko not_active Expired - Fee Related
- 1998-05-06 AP APAP/P/1999/001702A patent/AP1195A/en active
- 1998-05-06 TR TR1999/02997T patent/TR199902997T2/xx unknown
- 1998-05-12 ZA ZA983992A patent/ZA983992B/xx unknown
- 1998-05-12 AR ARP980102201A patent/AR011734A1/es active IP Right Grant
- 1998-05-12 MY MYPI98002118A patent/MY122262A/en unknown
- 1998-05-13 TW TW087107411A patent/TW479062B/zh active
- 1998-05-28 CO CO98030107A patent/CO4790174A1/es unknown
- 1998-05-31 JO JO19982034A patent/JO2034B1/en active
- 1998-06-01 PE PE1998000439A patent/PE84999A1/es not_active Application Discontinuation
- 1998-06-01 TN TNTNSN98075A patent/TNSN98075A1/fr unknown
- 1998-06-01 MA MA25093A patent/MA26502A1/fr unknown
- 1998-06-02 DZ DZ980119A patent/DZ2509A1/fr active
1999
- 1999-11-30 US US09/450,443 patent/US6586402B1/en not_active Expired - Fee Related
- 1999-12-01 NO NO19995891A patent/NO321786B1/no not_active IP Right Cessation
- 1999-12-02 OA OA9900266A patent/OA11305A/en unknown

Also Published As

Publication number	Publication date
CZ432999A3 (cs)	2000-06-14
HK1029124A1 (en)	2001-03-23
EP0882736A1 (fr)	1998-12-09
DE69801369D1 (de)	2001-09-20
NZ501463A (en)	2001-07-27
NO995891D0 (no)	1999-12-01
NO321786B1 (no)	2006-07-03
JP2002502396A (ja)	2002-01-22
IL133210A0 (en)	2001-03-19
DE69801369T2 (de)	2002-05-16
AP9901702A0 (en)	1999-12-31
AU7654198A (en)	1998-12-21
CA2292846C (fr)	2009-12-08
CN1134450C (zh)	2004-01-14
CZ299308B6 (cs)	2008-06-11
HUP0003592A2 (hu)	2001-02-28
AU746132B2 (en)	2002-04-18
AR011734A1 (es)	2000-08-30
OA11305A (en)	2003-08-25
US6586402B1 (en)	2003-07-01
PL337235A1 (en)	2000-08-14
RU2212247C2 (ru)	2003-09-20
PT984982E (pt)	2002-02-28
CA2292846A1 (fr)	1998-12-10
EP0984982B1 (fr)	2001-08-16
JP4346115B2 (ja)	2009-10-21
ES2166166T3 (es)	2002-04-01
EE9900546A (et)	2000-06-15
KR20010013286A (ko)	2001-02-26
MA26502A1 (fr)	2004-12-20
AP1195A (en)	2003-08-18
ZA983992B (en)	1998-11-20
HUP0003592A3 (en)	2001-05-28
TNSN98075A1 (fr)	2005-03-15
TR199902997T2 (xx)	2000-03-21
WO1998055505A1 (fr)	1998-12-10
PE84999A1 (es)	1999-09-15
ID24520A (id)	2000-07-20
PL195474B1 (pl)	2007-09-28
CO4790174A1 (es)	1999-05-31
MY122262A (en)	2006-04-29
NO995891L (no)	2000-02-01
KR100582510B1 (ko)	2006-05-23
EP0984982A1 (fr)	2000-03-15
DZ2509A1 (fr)	2003-01-25
EE03879B1 (et)	2002-10-15
CN1263535A (zh)	2000-08-16
BR9809910A (pt)	2000-08-01
JO2034B1 (en)	1999-05-15
ATE204297T1 (de)	2001-09-15
SI0984982T1 (en)	2002-02-28
TW479062B (en)	2002-03-11

Publication	Publication Date	Title
DK0984982T3 (da)	2001-11-12	LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem
HUP0100100A3 (en)	2001-12-28	Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
NO308298B1 (no)	2000-08-28	Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem
HUP0103265A3 (en)	2002-09-30	Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
ITRM960810A0 (it)	1996-11-27	Composizioni farmaceutiche contenenti ciclosporine o macrolidi
HUP0003349A3 (en)	2001-12-28	Peptide parathyroid hormone analogs, pharmaceutical compositions comprising thereof and their use
FI955042A7 (fi)	1995-11-29	Syklosporiinia sisältävä jauhemainen koostumus
DK1112266T3 (da)	2003-09-15	Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
HUP0103793A3 (en)	2003-09-29	N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them
EE03664B1 (et)	2002-04-15	Farmatseutilised aerosoolkompositsioonid
NO942835D0 (no)	1994-07-29	1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, fremstilling derav og farmasöytiske blandinger som inneholder dem
HUP0104934A3 (en)	2002-05-28	Peptide analogues of pacap, pharmaceutical compositions comprising thereof and their use
HUP0002272A3 (en)	2002-03-28	Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
NO976128D0 (no)	1997-12-29	Forbindelser og farmasöytiske blandinger som inneholder dem
HRP950612B1 (en)	2003-12-31	PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
FI954986L (fi)	1995-10-19	Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
HUP0001940A3 (en)	2002-09-30	Benzisothiazole derivatives, their use and pharmaceutical compositions containing them
DK1005342T3 (da)	2003-03-24	Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid
NO975365L (no)	1998-01-15	Benzopyraner og farmasöytiske sammensetninger inneholdende dem
HUP9802590A3 (en)	2001-08-28	Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
ZA9710254B (en)	1998-05-28	LH-RH peptide analogues, their uses and pharmaceutical composition containing them.
DK0776328T3 (da)	1999-07-19	8-fluoranthracycliner, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende dem
HUP9903500A3 (en)	2000-03-28	Thiophene-, furane- and pyrrolesulfonamides, their use and pharmaceutical compositions containing them
DK0979244T3 (da)	2005-06-27	Cyclosporinderivater, deres fremstilling og farmaceutiske præparater, der indeholder dem
IL123995A (en)	2005-08-31	Peptide derivatives, their preparation and pharmaceutical compositions comprising them